FDA Inspection 1312340 — Dr. Astrid Breitschaft
The FDA completed an inspection of Dr. Astrid Breitschaft on March 27, 2026 in Berlin. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- March 27, 2026
- Fiscal Year
- 2026
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Berlin (Germany)
Additional Details
Clinical BA/BE